MyMD Pharmaceuticals Announces Reverse Stock Split to Maintain Nasdaq Listing
Common Stock Will Begin Trading on Split-Adjusted Basis on February 15, 2024 BALTIMORE–(BUSINESS WIRE)–MyMD Pharmaceuticals, Inc.® (Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage biopharmaceutical company committed to developing…
Details